Xiaofeng Wu
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Xiang XuLuoquan AoWei XingWei GuoMengwei YaoXiang AoZhao–You TangXueting Hu
- Topics
- Cancer-related molecular mechanisms research (10 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers)RNA modifications and cancer (8 papers)
- Cited by
- Cancer ResearchHepatologyOncology
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaofeng Wu
97 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Molecular Biology 899
- Oncology 456
- Cancer Research 430
- Immunology 339
- Pulmonary and Respiratory Medicine 231
Countries citing papers authored by Xiaofeng Wu
This map shows the geographic impact of Xiaofeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Wu more than expected).
Fields of papers citing papers by Xiaofeng Wu
This network shows the impact of papers produced by Xiaofeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Wu. The network helps show where Xiaofeng Wu may publish in the future.
Co-authorship network of co-authors of Xiaofeng Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Wu. A scholar is included among the top collaborators of Xiaofeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Wu. Xiaofeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 8 | |
| 5 | 9 | |
| 6 | 6 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | 12 | |
| 11 | 1 | |
| 12 | 3 | |
| 13 | 38 | |
| 14 | METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancerbreakdown → | 276 |
| 15 | 7 | |
| 16 | 4 | |
| 17 | 12 | |
| 18 | 22 | |
| 19 | 62 | |
| 20 | 101 |
About Xiaofeng Wu
Xiaofeng Wu is a scholar working on Hepatology, Cancer Research and Oncology, having authored 105 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (430 citations), Hepatology (218 citations) and Oncology (456 citations). Xiaofeng Wu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xiang Xu, Luoquan Ao, Wei Xing, Wei Guo, Mengwei Yao, Xiang Ao, Zhao–You Tang, Xueting Hu, Yu Yang and Chengxiu Pu. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.